TRCT
EVH icon

Tower Research Capital (TRC)’s Evolent Health EVH Stock Holding History

Tower Research Capital (TRC)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3K Buy
10,649
+6,913
+185% +$21.9K ﹤0.01% 3333
2025
Q4 		$14.9K Buy
3,736
+338
+10% +$1.88K ﹤0.01% 3319
2025
Q3 		$28.7K Sell
3,398
-10,804
-76% -$105K ﹤0.01% 2976
2025
Q2 		$160K Buy
14,202
+10,770
+314% +$98.9K ﹤0.01% 1991
2025
Q1 		$32.5K Sell
3,432
-31,906
-90% -$322K ﹤0.01% 2554
2024
Q4 		$398K Buy
35,338
+28,345
+405% +$498K 0.01% 1224
2024
Q3 		$198K Sell
6,993
-15,671
-69% -$404K 0.01% 1627
2024
Q2 		$433K Buy
22,664
+21,407
+1,703% +$547K 0.01% 1457
2024
Q1 		$41.2K Sell
1,257
-24,264
-95% -$774K ﹤0.01% 2414
2023
Q4 		$843K Buy
25,521
+21,744
+576% +$615K 0.01% 979
2023
Q3 		$103K Buy
3,777
+1,626
+76% +$45.2K ﹤0.01% 1953
2023
Q2 		$65.2K Sell
2,151
-3,891
-64% -$126K ﹤0.01% 2363
2023
Q1 		$196K Buy
6,042
+5,182
+603% +$164K 0.01% 1381
2022
Q4 		$24K Sell
860
-5,299
-86% -$152K ﹤0.01% 2949
2022
Q3 		$221K Buy
6,159
+3,446
+127% +$121K ﹤0.01% 1836
2022
Q2 		$83K Sell
2,713
-7,843
-74% -$229K ﹤0.01% 2434
2022
Q1 		$341K Buy
10,556
+9,009
+582% +$236K ﹤0.01% 1395
2021
Q4 		$43K Sell
1,547
-2,290
-60% -$65.7K ﹤0.01% 2881
2021
Q3 		$119K Buy
3,837
+1,321
+53% +$31.7K ﹤0.01% 2241
2021
Q2 		$53K Sell
2,516
-3,694
-59% -$74K ﹤0.01% 2981
2021
Q1 		$126K Sell
6,210
-4,034
-39% -$76.7K ﹤0.01% 2399
2020
Q4 		$164K Sell
10,244
-81,118
-89% -$1.07M 0.01% 1884
2020
Q3 		$1.13M Buy
91,362
+68,381
+298% +$804K 0.01% 866
2020
Q2 		$164K Buy
22,981
+21,787
+1,825% +$146K 0.01% 1977
2020
Q1 		$6K Buy
1,194
+1,094
+1,094% +$9.77K ﹤0.01% 2222
2019
Q4 		$1K Sell
100
-17,930
-99% -$146K ﹤0.01% 3247
2019
Q3 		$129K Buy
+18,030
New +$129K 0.01% 1202
2019
Q2 		– Sell
-717
Closed -$9K – 3854
2019
Q1 		$9K Buy
717
+617
+617% +$9.77K ﹤0.01% 2726
2018
Q4 		$2K Sell
100
-44
-31% -$1.02K ﹤0.01% 3347
2018
Q3 		$4K Sell
144
-17,361
-99% -$414K ﹤0.01% 3184
2018
Q2 		$369K Buy
+17,505
New +$331K 0.02% 778
2018
Q1 		– Sell
-480
Closed -$6K – 3398
2017
Q4 		$6K Sell
480
-6,104
-93% -$86K ﹤0.01% 2809
2017
Q3 		$117K Buy
6,584
+6,484
+6,484% +$134K 0.01% 1202
2017
Q2 		$3K Sell
100
-1,211
-92% -$29.1K ﹤0.01% 2195
2017
Q1 		$30K Sell
1,311
-8,092
-86% -$155K ﹤0.01% 1022
2016
Q4 		$139K Buy
+9,403
New +$185K 0.02% 807
2016
Q2 		– Sell
-4,256
Closed -$45K – 4561
2016
Q1 		$45K Buy
4,256
+3,986
+1,476% +$41.2K 0.01% 831
2015
Q4 		$3K Sell
270
-20,632
-99% -$304K ﹤0.01% 3424
2015
Q3 		$334K Buy
20,902
+19,902
+1,990% +$388K 0.03% 200
2015
Q2 		$20K Buy
+1,000
New +$18.6K ﹤0.01% 2092

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s EVH Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Evolent Health (EVH) stake by 185% in Q1 2026, buying an estimated $21.9K and bringing the position to 10,649 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

Tower Research Capital (TRC) first reported a position in EVH in Q2 2015 and has held it in 40 quarters since. The position peaked at $1.13M in Q3 2020. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Tower Research Capital (TRC) held 10,649 shares of Evolent Health worth $24.3K as of Q1 2026.
  • Tower Research Capital (TRC) bought 6,913 Evolent Health shares in Q1 2026, an estimated $21.9K.
  • Evolent Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3333 holding.
  • Tower Research Capital (TRC) first reported a position in Evolent Health in Q2 2015 and has held it in 40 quarters since.
  • Tower Research Capital (TRC)'s Evolent Health position peaked at $1.13M in Q3 2020.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.